Cargando…

Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury

In previous research, Hugan Qingzhi, a traditional Chinese medicine, was shown to have protective effects against hepatic steatosis. However, its activity against non-alcoholic fatty liver disease (NAFLD) and the mechanisms by which it exerts its effects remain unknown. In the present study, the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Fan, Yao, Xiaorui, Tang, Waijiao, Xiao, Chunxin, Yang, Miaoting, Zhou, Benjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329039/
https://www.ncbi.nlm.nih.gov/pubmed/28293193
http://dx.doi.org/10.3389/fphar.2017.00099
_version_ 1782510980070113280
author Xia, Fan
Yao, Xiaorui
Tang, Waijiao
Xiao, Chunxin
Yang, Miaoting
Zhou, Benjie
author_facet Xia, Fan
Yao, Xiaorui
Tang, Waijiao
Xiao, Chunxin
Yang, Miaoting
Zhou, Benjie
author_sort Xia, Fan
collection PubMed
description In previous research, Hugan Qingzhi, a traditional Chinese medicine, was shown to have protective effects against hepatic steatosis. However, its activity against non-alcoholic fatty liver disease (NAFLD) and the mechanisms by which it exerts its effects remain unknown. In the present study, the effects of Hugan Qingzhi on free fatty acid (FFA)-induced L02 cells were examined. The techniques of iTRAQ labeling, together with strong cation exchange-non-liquid chromatography–tandem mass spectrometry (SCX-non-LC-MS/MS) analysis and serum pharmacology, were used to evaluate the effects of Hugan Qingzhi-medicated serum on FFA-induced L02 hepatocyte injury. Results identified 355 differentially expressed proteins following FFA treatment, compared with a control group; 359 altered proteins in the Hugan Qingzhi high dose + FFA treatment group, compared with the FFA treatment group; and 365 altered proteins in the Hugan Qingzhi high dose + FFA treatment group, compared with the control group. Based on the Kyoto Encyclopedia of Gene and Genomes pathway enrichment analysis, it is concluded that several pathways including those of microbial metabolism in diverse environments, fatty acid metabolism, peroxisome proliferator activated receptor signaling, and mitogen-activated protein kinase signaling are closely associated with the effects of Hugan Qingzhi-medicated serum in FFA-induced L02 hepatocyte injury. Furthermore, several differentially expressed proteins, including heat shock protein 27 (HSP27), acetyl-CoA acetyltransferase 1, calnexin, and integrin-linked kinase, were validated by western blotting. A target-specific HSP27 siRNA was used to investigate further the function of HSP27, and it was found that HSP27 might have a key role in the observable effects of Hugan Qingzhi-medicated serum in FFA-induced L02 hepatocyte injury. The results not only confirmed that Hugan Qingzhi exhibits a significant protective effect in FFA-induced L02 hepatocyte injury, but also suggest insights into the mechanism of such protective effects.
format Online
Article
Text
id pubmed-5329039
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53290392017-03-14 Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury Xia, Fan Yao, Xiaorui Tang, Waijiao Xiao, Chunxin Yang, Miaoting Zhou, Benjie Front Pharmacol Pharmacology In previous research, Hugan Qingzhi, a traditional Chinese medicine, was shown to have protective effects against hepatic steatosis. However, its activity against non-alcoholic fatty liver disease (NAFLD) and the mechanisms by which it exerts its effects remain unknown. In the present study, the effects of Hugan Qingzhi on free fatty acid (FFA)-induced L02 cells were examined. The techniques of iTRAQ labeling, together with strong cation exchange-non-liquid chromatography–tandem mass spectrometry (SCX-non-LC-MS/MS) analysis and serum pharmacology, were used to evaluate the effects of Hugan Qingzhi-medicated serum on FFA-induced L02 hepatocyte injury. Results identified 355 differentially expressed proteins following FFA treatment, compared with a control group; 359 altered proteins in the Hugan Qingzhi high dose + FFA treatment group, compared with the FFA treatment group; and 365 altered proteins in the Hugan Qingzhi high dose + FFA treatment group, compared with the control group. Based on the Kyoto Encyclopedia of Gene and Genomes pathway enrichment analysis, it is concluded that several pathways including those of microbial metabolism in diverse environments, fatty acid metabolism, peroxisome proliferator activated receptor signaling, and mitogen-activated protein kinase signaling are closely associated with the effects of Hugan Qingzhi-medicated serum in FFA-induced L02 hepatocyte injury. Furthermore, several differentially expressed proteins, including heat shock protein 27 (HSP27), acetyl-CoA acetyltransferase 1, calnexin, and integrin-linked kinase, were validated by western blotting. A target-specific HSP27 siRNA was used to investigate further the function of HSP27, and it was found that HSP27 might have a key role in the observable effects of Hugan Qingzhi-medicated serum in FFA-induced L02 hepatocyte injury. The results not only confirmed that Hugan Qingzhi exhibits a significant protective effect in FFA-induced L02 hepatocyte injury, but also suggest insights into the mechanism of such protective effects. Frontiers Media S.A. 2017-02-28 /pmc/articles/PMC5329039/ /pubmed/28293193 http://dx.doi.org/10.3389/fphar.2017.00099 Text en Copyright © 2017 Xia, Yao, Tang, Xiao, Yang and Zhou. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xia, Fan
Yao, Xiaorui
Tang, Waijiao
Xiao, Chunxin
Yang, Miaoting
Zhou, Benjie
Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
title Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
title_full Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
title_fullStr Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
title_full_unstemmed Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
title_short Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury
title_sort isobaric tags for relative and absolute quantitation (itraq)-based proteomic analysis of hugan qingzhi and its protective properties against free fatty acid-induced l02 hepatocyte injury
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329039/
https://www.ncbi.nlm.nih.gov/pubmed/28293193
http://dx.doi.org/10.3389/fphar.2017.00099
work_keys_str_mv AT xiafan isobarictagsforrelativeandabsolutequantitationitraqbasedproteomicanalysisofhuganqingzhianditsprotectivepropertiesagainstfreefattyacidinducedl02hepatocyteinjury
AT yaoxiaorui isobarictagsforrelativeandabsolutequantitationitraqbasedproteomicanalysisofhuganqingzhianditsprotectivepropertiesagainstfreefattyacidinducedl02hepatocyteinjury
AT tangwaijiao isobarictagsforrelativeandabsolutequantitationitraqbasedproteomicanalysisofhuganqingzhianditsprotectivepropertiesagainstfreefattyacidinducedl02hepatocyteinjury
AT xiaochunxin isobarictagsforrelativeandabsolutequantitationitraqbasedproteomicanalysisofhuganqingzhianditsprotectivepropertiesagainstfreefattyacidinducedl02hepatocyteinjury
AT yangmiaoting isobarictagsforrelativeandabsolutequantitationitraqbasedproteomicanalysisofhuganqingzhianditsprotectivepropertiesagainstfreefattyacidinducedl02hepatocyteinjury
AT zhoubenjie isobarictagsforrelativeandabsolutequantitationitraqbasedproteomicanalysisofhuganqingzhianditsprotectivepropertiesagainstfreefattyacidinducedl02hepatocyteinjury